Drugs / A/Vietnam/1194 H5N1 vaccine
last change Sep 2013 re-read 2 minutes ago

A/Vietnam/1194 H5N1 vaccine

Vaccine

Developed for
influenza
Investigated by
Centers for Disease Control and Prevention · Novartis · Public Health England · University Hospitals, Leicester

Trials 1 · a red edge is where a trial was stopped

2009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00798343 Jan 2009 → Mar 2010 influenza University Hospitals, Leicester Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as A/Vietnam/1194 H5N1 vaccine “MF59-adjuvanted A/Vietnam/1194 H5N1 vaccine 7.5ug dose” NCT00798343
Modality Vaccine “MF59-adjuvanted A/Vietnam/1194 H5N1 vaccine 7.5ug dose” NCT00798343
Route Intramuscular “To evaluate safety of one or two IM doses of MF59-adjuvanted A/Vietnam/1194/2004 (H5N1) influenza vaccine, containing 7.5 μg of H5 antigen in adult subjects” NCT00798343